You are here

Article Text

Article menu
Download PDFPDF
Miscellanea
Journal club
Does the addition of high-dose vitamin D3 reduce the period of time required for the treatment of pulmonary tuberculosis?
  1. Jessica Reed
  1. Correspondence to Dr Jessica Reed, FY1, South Tees Hospitals NHS Trust, Middlesbrough, UK; jessica.reed{at}nhs.net

https://doi.org/10.1136/thoraxjnl-2011-200114

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    This double-blind randomised placebo control trial investigated the addition of four doses of 2.5 mg of vitamin D3 to intensive phase antimicrobial therapy (isoniazid, rifampicin, pyrazinamide and ethambutol) for tuberculosis and the effect upon culture conversion rates. Time to conversion was measured at 14, 28, 42 and 56 days compared …

    View Full Text